GERALD BAGG - 25 Jul 2022 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Role
Director
Signature
/s/ Joel M. Bennett, Attorney-in-Fact for Gerald Bagg
Issuer symbol
AVRW
Transactions as of
25 Jul 2022
Transactions value $
$0
Form type
4
Filing time
15 Sep 2022, 18:11:35 UTC
Previous filing
23 Aug 2022
Next filing
21 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVRW Common Stock Award $0 +220,795 $0 220,795 25 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This late filing is due to an inadvertent administrative error and not any error of the Reporting Person.
F2 Represents the grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan pursuant to the Issuer's Non-Employee Director Compensation Policy. The RSUs will vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service through the vesting date. The RSUs will vest in full immediately prior to the consummation of a change in control of the Issuer. The RSUs will be settled in shares of the Issuer's common stock upon vesting.

Remarks:

Exhibit 24 - Power of Attorney